Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

AACR, Bayer to fund fellowships to advance cancer research The American Association for Cancer Research (AACR) and Bayer HealthCare are pleased to announce a new partnership that will expand AACR's Basic Cancer Research Fellowship Program for 2015.
Contract Research & Services > Contract Research > News
Medimmune, Cambridge University partner to facilitate breakthrough biopharmaceutical research By PBR Staff Writer
AstraZeneca's global biologics R&D arm MedImmune has entered into a new five-year, multi-project collaboration with the University of Cambridge's Department of Chemical Engineering and Biotechnology (CEB) to focus on generating breakthrough research in biopharmaceutical development (BPD).
Contract Research & Services > Contract Research > News Sophiris Bio begins dosing in Phase IIa proof of concept prostate cancer trial of PRX302 By PBR Staff Writer
Sophiris Bio has dosed first patients in a single-center, open-label Phase IIa proof of concept trial of PRX302, a clinical-stage, targeted therapy, as a treatment for localized low to intermediate risk prostate cancer.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
PEI funds treatment with Aubagio for relapsing remitting multiple sclerosis
Genzyme, a Sanofi company, announced that PEI Pharmacare has included Aubagio (teriflunomide) 14mg on the provincial drug formulary as a first-line oral tablet for people in the province living with relapsing remitting multiple sclerosis (RRMS).
Contract Research & Services > Contract Research > News
Growing Potential: mAb Production With Fibra-Cel
| By Eppendorf
The market for monoclonal antibodies continues to grow steadily, but there are still bottlenecks in the development of new products, including long development times mostly due to R&D. Advanced bioprocess equipment that meets the specific demands of mAb-producing hybridoma can accelerate design and production, and reduce overall development costs along the way.
Contract Research & Services > Contract Research > White Papers
DoE Bioprocess Development
| By Eppendorf
Eppendorf DASware is the effective route to design of experiments (DoE) in early-stage bioprocess development. Claudia M Huether-Franken and Sebastian Kleebank explain how the design software applies DoE to DASGIP parallel bioreactor systems.
Contract Research & Services > Contract Research > White Papers
Taking the Strain
| By Eppendorf
Today, the rapidly expanding demand for vaccine products for viral diseases such as rabies has necessitated the development of more sophisticated production techniques based around cell culture systems. This article reviews vaccine production strategies, with a focus on rabies, looking specifically at the use of the Vero cell line - used worldwide and approved by the US Food and Drug Administration - as well as media technology and the bioreactor options available.
Contract Research & Services > Contract Research > White Papers
Boehringer, Eureka Therapeutics to develop new antibodies for cancer treatment
By PBR Staff Writer
German pharmaceutical firm Boehringer Ingelheim has entered into a research agreement with US-based Eureka Therapeutics to discover new therapeutic antibodies in oncology.
Contract Research & Services > Contract Research > News
Novare enters into research agreement with Lawson Health Research Institute
Novare Pharmaceuticals, which is developing therapeutic products that modulate the Receptor for Hyaluronan-Mediated Motility (RHAMM), is pleased to announce a research and licensing agreement with Lawson Health Research Institute that includes the creation of an incubator focused on potential treatments for major diseases, including arthritis, breast cancer, and lung fibrosis.
Contract Research & Services > Contract Research > News
Melinta's phase III trial shows significant burden of obesity on patients' recovery from ABSSSI
Melinta Therapeutics presented data that show the negativeimpact of obesity on patients' recovery from acute bacterial skinand skin structure infections (ABSSSI).
Contract Research & Services > Contract Research > News
Amino Acid Analysis in Pharmaceuticals
| By Butterworth Laboratories Ltd
The European Pharmacopeia (Ph Eur) is moving away from the historical Thin Layer Chromatography technique (TLC) for the determination of Ninhydrin-positive substances, to more specific and sensitive methods utilising Liquid Chromatography (LC) or Amino Acid Analysers. This paper will explore the history of the test, the benefits of the change and considerations for validation of the LC approach to analysis.
Contract Research & Services > Contract Research > White Papers
Enhanced Residual Solvents Analysis: A Practical Approach to Sampling, Transport, Storage and Analysis.
| By Butterworth Laboratories Ltd
Residual solvents are organic volatile chemicals used or produced in the manufacture of active pharmaceutical ingredients (API), excipients or drug products, which remain in the material at the end of the manufacturing process. Their control is important in limiting exposure and guidelines exist to maintain patient safety, not just to satisfy competent authorities. It is a requirement that all pharmaceutical substances comply with ICH limits even if not required by individual monographs or if no compendial monograph exists.
Contract Research & Services > Contract Research > White Papers
Elemental Impurity Analysis in Pharmaceuticals
| By Butterworth Laboratories Ltd
A method to identify the presence of heavy metals in pharmaceuticals was introduced in the United States Pharmacopoeia more than 100 years ago. Today pharmaceutical companies are still using essentially the same method, the USP <231> Heavy Metals Limit Test. This paper will give an overview of the current method limitations, considerations for the new methodology and the risk-based assessments being carried out by manufacturers.
Contract Research & Services > Contract Research > White Papers
View all Contract Research news or find news targeted to your interests